Skip to main content
VITEK® SOLUTION

Comprehensive and Automated ID & AST Solution

VITEK® SOLUTIONS

A complete automated offer for identification and antimicrobial susceptibility testing that truly pushes back technology limits to innovate microbiology. 

VITEK® SOLUTIONS – Innovating Microbiology

Innovating microbiology is at the heart of VITEK® SOLUTIONS. With our constant advances in workflow efficiency and integration, we provide fast and accurate ID & AST results to offer you critical insights for antimicrobial stewardship. . Efficient workflow equals efficient labs and time recaptured. VITEK® SOLUTIONS allows you to focus on challenging situations and value-added tasks. Designed by microbiologists for microbiologists, count on VITEK® SOLUTIONS to accompany all your ID & AST needs from routine to critical patient challenges.  

  

Drive your Antimicrobial Stewardship (AMS) Programs with Diagnostics

VITEK® SOLUTIONS offers a fully integrated, automated ID & AST solution for faster and more reliable results. The regularly updated databases and panels keep pace with new emerging pathogens, clinically relevant species, and breakpoints to provide more informed decisions sooner to support AMS programs and improve patient care.  

  

Make More Informed Therapy Decisions Sooner

Whether you are faced with routine testing, unusual or resistant organisms, or critical clinical situations, VITEK® SOLUTIONS enables you to confidently deliver results with excellent speed and accuracy. The combined solutions have been shown to get results to clinicians 14 to 20 hours earlier1,2,3, facilitating clinical decision-making for optimal treatment.4

  

VITEK® SOLUTIONS has constantly pushed back technology limits to improve patient care for over 30 years and will resolutely continue to do so.

  

VITEK® SOLUTIONS

The completeness of VITEK® SOLUTIONS provides multiple choices that can evolve over time to meet increasing productivity goals. 

Disclaimer: Product availability varies by country. Please consult your local bioMérieux representative for product availability in your country.

  • VITEK® 2

    Fully integrated Identification and Antimicrobial Susceptibility Testing

    VITEK® 2, the leading automated system for routine antimicrobial susceptibility testing, provides efficient workflow, faster AST results. Its fully-integrated ID & AST approach ensures superior performance to rapidly and confidently guide therapy.

  • VITEK® 2 COMPACT

    Compact, automated ID/AST instrument

    The compact solution for fast, accurate ID/AST testing with expert confidence

  • VITEK® 2 ID & AST Cards

    Rapid. Flexible. Efficient.

    Providing accurate and reliable identification and antimicrobial susceptibility results for clinically relevant organisms with self-contained, disposable test cards designed for VITEK® 2 automated systems.

  • VITEK® MS

    Microbial Identification in Minutes

    VITEK® MS provides rapid and robust identification of microorganisms delivering clinicians with actionable results to support informed treatment decisions.

  • VITEK® MS PRIME

    New-Generation Mass Spectrometry Microbial Identification System

    VITEK® MS PRIME combines microbiology expertise with innovation taking mass spectrometry to the next level by maximizing the impact of daily laboratory workflow for better patient care. 

  • VITEK® REVEAL™

    Rapid Antimicrobial Susceptibility Testing (AST) for Bloodstream Infections

    The newest addition to our Sepsis Solution, VITEK® REVEAL™ offers rapid AST results to effectively and efficiently manage bloodstream infections.

  • Previous
  • 1
  • Next

Resources

  

Customer Testimonials

Contact Us for Information on VITEK® SOLUTIONS

Contact Us

      

    References

    1. Kaleta and Wolk, Clin Lab News ; May 2012

    2. Barenfanger et al. JCM 1999 37 (5) 1415

    3. Galar et al. EJMID 2012 31 (9) 2445

    4. Cavalieri SJ et al. Diagnostic Microbiology and Infectious Disease. 2019; Vol 92 (2):208-211. Effect of antimicrobial stewardship with rapid MALDI-TOF identification and VITEK® 2 antimicrobial susceptibility testing on hospitalization outcome: https://pubmed.ncbi.nlm.nih.gov/31279585/